Arbeitsgemeinschaft medikamentoese Tumortherapie

OrganisationROR

Trials

  • NCT04891809

    Phase 2, Active, not recruiting, 198 people, 18 May 2021

  • NCT03948035

    Collaborator, Phase 3, Active, not recruiting, 576 people, 13 May 2019

  • NCT03792763

    Phase 2, Completed, 8 people, 3 Jan 2019

  • NCT02993094

    Phase 1/2, Terminated, 31 people, 15 Dec 2016

  • NCT02987400

    Phase 2, Completed, 22 people, 9 Dec 2016

  • NCT02891811

    Phase 2, Completed, 124 people, 8 Sept 2016

  • NCT02462538

    Phase 1/2, Terminated, 3 people, 4 Jun 2015

  • NCT02410694

    Phase 2, Completed, 90 people, 8 Apr 2015

  • NCT02236936

    Phase 3, Terminated, 8 people, 11 Sept 2014

  • NCT01884259

    Phase 2, Completed, 100 people, 24 Jun 2013

  • NCT01351038

    Phase 2, Terminated, 43 people, 10 May 2011

  • NCT00952003

    Phase 2, Completed, 40 people, 4 Aug 2009

  • NCT00575406

    Phase 2, Completed, 94 people, 18 Dec 2007